Liu Yan-Qiu | China–Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University
スポンサーリンク
概要
- 同名の論文著者
- China–Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical Universityの論文著者
関連著者
-
Tashiro Shin-ichi
Dep. Of Clinical And Biomedical Sciences Showa Pharmaceutical Univ. Jpn
-
TASHIRO Shin-ichi
Department of Clinical and Biomedical Sciences, Showa Pharmaceutical University
-
ONODERA Satoshi
Department of Clinical and Biomedical Sciences, Showa Pharmaceutical University
-
IKEJIMA Takashi
China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical Unive
-
Onodera S
Dep. Of Clinical And Biomedical Sciences Showa Pharmaceutical Univ. Jpn
-
Onodera Satoshi
昭和薬科大学 病態科
-
Ikejima Takashi
China-japan Res. Inst. Of Medical And Pharmaceutical Sciences Shenyang Pharmaceutical Univ. Chn
-
LIU Yan-Qiu
China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical Unive
-
YOU Song
Laboratory of Natural Product Biotechnology, Shenyang Pharmaceutical University
-
Tashiro Shin-ichi
Department Of Clinical And Biomedical Sciences Showa Pharmaceutical University
著作論文
- Fas/FasL Signaling Allows Extracelluar-Signal Regulated Kinase to Regulate Cytochrome c Release in Oridonin-Induced Apoptotic U937 Cells(Pharmacology)
- Activation of Phosphoinositide 3-Kinase, Protein Kinase C, and Extracellular Signal-Regulated Kinase Is Required for Oridonin-Enhanced Phagocytosis of Apoptotic Bodies in Human Macrophage-Like U937 Cells